Literature DB >> 25691445

A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups.

Bhuma Krishnamachari1, Dora Il'yasova2, Michael E Scheurer3, Melissa Bondy3, Renke Zhou3, Margaret Wrensch4, Faith Davis5.   

Abstract

PURPOSE: The incidences of atopic conditions (allergies, asthma, or eczema) and glioma vary by ethnicity. Atopic conditions are inversely associated with gliomas. We conducted a pooled multisite study investigating the associations of atopic conditions with glioma in different race/ethnicity groups.
METHODS: Using glioma cases and healthy controls, unconditional logistic regression was conducted to assess the associations of atopic conditions with glioma separately in white, black, Asian, and Hispanic subpopulations. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
RESULTS: Glioblastoma multiforme cases were less likely than controls to report a history of atopic conditions in whites (OR = 0.46, [95% CI, 0.38-0.54]) and Asians (OR = 0.27, [95% CI, 0.10-0.73]). The same trend was seen when looking at glioma cases of all histologies. An inverse association was not seen in blacks for glioblastoma multiforme or all histologies combined.
CONCLUSIONS: The inverse association between glioma and atopic conditions may vary by ethnicity due to a difference in the biology of atopic conditions in different ethnicities but may be due to chance because of the limitations of small nonwhite sample sizes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergies; Atopic conditions; Glioma

Mesh:

Year:  2015        PMID: 25691445      PMCID: PMC4454363          DOI: 10.1016/j.annepidem.2014.12.007

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  32 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 2.  Racial differences in allergic sensitization: recent findings and future directions.

Authors:  Ganesa Wegienka; Christine Cole Johnson; Edward Zoratti; Suzanne Havstad
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

3.  History of allergies and risk of glioma in adults.

Authors:  Minouk J Schoemaker; Anthony J Swerdlow; Sarah J Hepworth; Patricia A McKinney; Martie van Tongeren; Kenneth R Muir
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

4.  Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.

Authors:  Jian-Ying Sun; Chun-Yang Zhang; Zhen-Jun Zhang; Yan-Fang Dong; An-Long Zhang; Zhi-Wei Wang; Xiao-Long Mei
Journal:  Asian Pac J Cancer Prev       Date:  2012

5.  Risk factors for oligodendroglial tumors: a pooled international study.

Authors:  Bridget J McCarthy; Kristin M Rankin; Ken Aldape; Melissa L Bondy; Thomas Brännström; Helle Broholm; Maria Feychting; Dora Il'yasova; Peter D Inskip; Christoffer Johansen; Beatrice S Melin; Avima M Ruder; Mary Ann Butler; Michael E Scheurer; Joachim Schüz; Judith A Schwartzbaum; Margaret R Wrensch; Faith G Davis
Journal:  Neuro Oncol       Date:  2010-12-10       Impact factor: 12.300

6.  History of allergies among adults with glioma and controls.

Authors:  Joseph L Wiemels; John K Wiencke; Jennette D Sison; Rei Miike; Alex McMillan; Margaret Wrensch
Journal:  Int J Cancer       Date:  2002-04-01       Impact factor: 7.396

7.  Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand.

Authors:  Michelle C Turner; Daniel Krewski; Bruce K Armstrong; Angela Chetrit; Graham G Giles; Martine Hours; Mary L McBride; Marie-Élise Parent; Siegal Sadetzki; Jack Siemiatycki; Alistair Woodward; Elisabeth Cardis
Journal:  Cancer Causes Control       Date:  2013-02-27       Impact factor: 2.506

8.  Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995.

Authors:  Shuji Yonehara; Alina V Brenner; Masao Kishikawa; Peter D Inskip; Dale L Preston; Elaine Ron; Kiyohiko Mabuchi; Shoji Tokuoka
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

9.  Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.

Authors:  Dora Il'yasova; Bridget McCarthy; Jennifer Marcello; Joellen M Schildkraut; Patricia G Moorman; Bhuma Krishnamachari; Francis Ali-Osman; Darell D Bigner; Faith Davis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

10.  Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007.

Authors:  Robert Dubrow; Amy S Darefsky
Journal:  BMC Cancer       Date:  2011-07-29       Impact factor: 4.430

View more
  8 in total

1.  Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.

Authors:  E Susan Amirian; Renke Zhou; Margaret R Wrensch; Sara H Olson; Michael E Scheurer; Dora Il'yasova; Daniel Lachance; Georgina N Armstrong; Lucie S McCoy; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Jonine L Bernstein; Ryan T Merrell; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

2.  Allergies and Asthma in Relation to Cancer Risk.

Authors:  Elizabeth D Kantor; Meier Hsu; Mengmeng Du; Lisa B Signorello
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-05       Impact factor: 4.254

Review 3.  Risk factors for childhood and adult primary brain tumors.

Authors:  Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

4.  A Modern Radiotherapy Series of Survival in Hispanic Patients with Glioblastoma.

Authors:  Cheng-Chia Wu; Tony J C Wang; Ashish Jani; Juan P Estrada; Timothy Ung; Daniel S Chow; Jennifer E Soun; Shumaila Saad; Yasir H Qureshi; Robyn Gartrell; Heva J Saadatmand; Anurag Saraf; Matthew D Garrett; Christopher S Grubb; Steven R Isaacson; Simon K Cheng; Michael B Sisti; Jeffrey N Bruce; Sameer A Sheth; Andrew B Lassman; Guy M McKhann
Journal:  World Neurosurg       Date:  2015-12-31       Impact factor: 2.104

Review 5.  Newly Diagnosed Glioblastoma: A Review on Clinical Management.

Authors:  Rimas V Lukas; Derek A Wainwright; Erik Ladomersky; Sean Sachdev; Adam M Sonabend; Roger Stupp
Journal:  Oncology (Williston Park)       Date:  2019-03-13       Impact factor: 2.990

6.  Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.

Authors:  Courtney Duong; Thien Nguyen; John P Sheppard; Vera Ong; Lawrance K Chung; Daniel T Nagasawa; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

7.  Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.

Authors:  Jit Chatterjee; Shilpa Sanapala; Olivia Cobb; Alice Bewley; Andrea K Goldstein; Elizabeth Cordell; Xia Ge; Joel R Garbow; Michael J Holtzman; David H Gutmann
Journal:  Nat Commun       Date:  2021-12-08       Impact factor: 14.919

Review 8.  Evidence from a large-scale meta-analysis indicates eczema reduces the incidence of glioma.

Authors:  Guannan Wang; Suling Xu; Chao Cao; Jing Dong; Yudong Chu; Guijuan He; Zhiwei Xu
Journal:  Oncotarget       Date:  2016-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.